EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
   2.6.1.64 | phenylpyruvate + L-leucine |
about 25% the rate exhibited with L-phenylalanine and alpha-oxo-gamma-methiolbutyrate |
Homo sapiens |
? |
- |
? |
| 2.6.1.64 | phenylpyruvate + L-methionine |
about 30% the rate exhibited with L-phenylalanine and alpha-oxo-gamma-methiolbutyrate |
Homo sapiens |
? |
- |
? |
| 2.6.1.64 | S-(1,1,2,2-tetrafluoroethyl)-L-cysteine + 4-(methylsulfanyl)-2-oxobutanoate |
about 63% the rate exhibited with L-phenylalanine and alpha-oxo-gamma-methiolbutyrate |
Homo sapiens |
? |
- |
? |
| 2.6.1.64 | S-(1,2-dichlorovinyl)-L-cysteine + 4-(methylsulfanyl)-2-oxobutanoate |
about 13% the rate exhibited with L-phenylalanine and alpha-oxo-gamma-methiolbutyrate |
Homo sapiens |
? |
- |
? |
| 2.6.1.64 | S-aminoethyl-L-cysteine + phenylpyruvate |
- |
Bos taurus |
S-aminoethyl-(3-mercapto-2-oxopropanoate) + L-phenylalanine |
- |
r |
| 2.6.1.64 | S-aminoethyl-L-cysteine + phenylpyruvate |
- |
Bos taurus |
2H-1,4-thiazine-5,6-dihydro-3-carboxylic acid + L-phenylalanine + H2O |
- |
r |
| 2.6.1.64 | S-aminomethyl-L-cysteine + phenylpyruvate |
- |
Bos taurus |
2H-1,4-thiazine-5,6-dihydro-3-carboxylic acid + L-phenylalanine |
- |
? |
| 2.6.1.64 | S-carbamoyl-L-cysteine + glyoxylate |
- |
Rattus norvegicus |
S-carbamoyl-3-mercapto-2-oxo-propanoate + glycine |
- |
r |
| 2.6.1.64 | S-methyl-L-cysteine + glyoxylate |
- |
Rattus norvegicus |
3-methylsulfanyl-2-oxopropanoate + glycine |
- |
r |
| 2.6.1.64 | S-methyl-L-cysteine + phenylpyruvate |
- |
Rattus norvegicus |
3-methylsulfanyl-2-oxopropanoate + L-phenylalanine |
- |
r |
